Category Archives: Business and Investments

Latest From Business and Investments

Take a look at our New Partnering Guide

We’ve just finished creating a new guide to the BIO One-on-One Partnering System! Step-by-Step Instructions for Partnering Success. It’s designed to be an easy overview of how get started with the system, with a few tips and tricks along the way. You can find it whenever you visit the WWGD blog, too, by visiting the Resources page. If you have specific questions or need help with partnering, please leave a comment, or feel free to Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Europe Spring – State of the Biotech Industry

BIO Industry Analysis provided opening remarks at BIO Europe Spring in Milan, Italy, this morning.  Dr. John Craighead shared the highlights of BIO’s latest industry update: click here for the slides in pdf format.

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Anitbody Deals Peaked in 2007

Antibody and antibody-like scaffold molecules have been on the pharma licensing radar for some time. The pharma business development interest in these drug candidates stems largely from the targeted mechanisms of action, structural uniqueness of the molecules, strong IP, and portfolio diversification benefits. To analyze deal trends in this niche area of biotechnology, we screened the Windhover/Elsevier Strategic Transactions Database for “Biotechnology” deals, with “Antibody” or “Large Molecule” identifiers, from 2007-2010. From this initial list, Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,

A Partner in Partnering: BIO and the China Healthcare Investment Conference

If you’re attending the China Healthcare Investment Conference this month, you’ll probably notice something familiar. BIO has partnered with the Lychee Group to use the One-on-One Partnering System during their event! The event focuses on the most influential Chinese and global thought leaders to promote the development of the Chinese healthcare market, and all attendees will now be able to send requests, schedule meetings, and connect with one another in private meetings. As with all Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , ,

2011, The Year of Positive Thinking? BIO/IPREO Study Reveals High Hopes for the Industry

BIO CEO’s closing plenary session featured plenty of crystal ball gazing and candid quips about what 2011 has in store for the biotech industry.  While the panel provided an in-depth look at how buy-side and sell-side analysts evaluate the industry, the BIO/IPREO Investor Perception Study reveals that the majority of investors believe biotech is headed in the right direction.  Access full study deck here: BIO CEO – IPREO Biotech Investor Perception Study The study also reveals that Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,